- $116.26m
- $145.26m
- $94.64m
Brief: Societal Cdmo Announces Offerings Of Common Stock And Preferred Stock
Brief: Societal CDMO Signs $39 Million Sale And Leaseback Transaction Agreement With Tenet Equity
Brief: Cingulate Inc Reports Q3 Loss Of $0.36 Per Share
Societal CDMO Inc reports results for the quarter ended in September - Earnings Summary
Brief: Societal CDMO Reports Third Quarter 2022 Financial Results
Societal CDMO Inc expected to post a loss of 6 cents a share - Earnings Preview
Brief: Cingulate Announces Agreement With Societal Cdmo
Brief: Societal Cdmo Announces Signing Of Multiple New Cdmo Service Agreements
Brief: Societal CDMO Appoints Elena Cant To Board Of Directors
Brief: Societal Cdmo Awarded Two New Cdmo Service Contracts Focused On Supporting Ongoing Clinical Development Programs For Novel Therapeutic Candidates
Brief: Societal CDMO - On Aug 18, Received Letter From Nasdaq Confirming Co Regained Compliance With Nasdaq’S Minimum Bid Price Continuing Listing Requirement
Brief: Societal CDMO announces signing of more than $9 million sales and purchase agreement with David Weekley Homes for Excess Lakefront Land
Societal CDMO Inc reports results for the quarter ended in June - Earnings Summary
Brief: Societal Cdmo Reports Second Quarter 2022 Financial Results
Societal CDMO Inc expected to post a loss of 8 cents a share - Earnings Preview
Brief: Societal CDMO Adds Three New Customers
Brief: Societal CDMO Selected To Provide Services To Support Development Of Oral Solid Dose Product In Europe
Brief: Societal CDMO - On June 27, 2022, Co, Received A Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard From Nasdaq
Brief: Societal CDMO Announces Key New Customer Project Within Automated Fill/Finish And Lyophilization Unit At San Diego Facility